HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The phosphatase activity of laforin is dispensable to rescue Epm2a-/- mice from Lafora disease.

Abstract
Lafora progressive myoclonus epilepsy (Lafora disease) is a fatal autosomal recessive neurodegenerative disorder characterized by the presence of glycogen-like intracellular inclusions called Lafora bodies. The vast majority of patients carry mutations in either the EPM2A or EPM2B genes, encoding laforin, a glucan phosphatase, and malin, an E3 ubiquitin ligase, respectively. Although the precise physiological role of these proteins is not fully understood, work in past years has established a link between glycogen synthesis, Lafora bodies formation and Lafora disease development. To determine the role of the phosphatase activity of laforin in disease development we generated two Epm2a(-/-) mouse lines expressing either wild-type laforin or a mutant (C265S) laforin lacking only the phosphatase activity. Our results demonstrate that expression of either transgene blocks formation of Lafora bodies and restores the impairment in macroautophagy, preventing the development of Lafora bodies in Epm2a(-/-) mice. These data indicate that the critical pathogenic process is the control of abnormal glycogen accumulation through intracellular proteolytic systems by the laforin-malin complex, and not glycogen dephosphorylation by laforin. Understanding which is the essential process leading to Lafora disease pathogenesis represents a critical conceptual advance that should facilitate development of appropriate therapeutics.
AuthorsJavier Gayarre, Lara Duran-Trío, Olga Criado Garcia, Carmen Aguado, Lucia Juana-López, Inmaculada Crespo, Erwin Knecht, Paola Bovolenta, Santiago Rodríguez de Córdoba
JournalBrain : a journal of neurology (Brain) Vol. 137 Issue Pt 3 Pg. 806-18 (Mar 2014) ISSN: 1460-2156 [Electronic] England
PMID24430976 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dual-Specificity Phosphatases
  • Epm2a protein, mouse
  • Protein Tyrosine Phosphatases, Non-Receptor
Topics
  • Animals
  • Autophagy (genetics)
  • Disease Models, Animal
  • Dual-Specificity Phosphatases (deficiency, genetics, metabolism)
  • Female
  • Lafora Disease (enzymology, genetics, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Mutation
  • Phosphorylation (genetics)
  • Protein Tyrosine Phosphatases, Non-Receptor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: